Upfront Matched Unrelated Donor Transplantation in Aplastic Anemia.
Clesham K, Dowse R, Samarasinghe S.
Hematol Oncol Clin North Am. 2018 Aug;32(4):619-628. doi: 10.1016/j.hoc.2018.03.004. Epub 2018 May 28.
Expanding post-transplant cyclophosphamide to matched unrelated donor transplants and beyond.
Gooptu M, Bolaños-Meade J, Koreth J.
Blood Rev. 2023 Nov;62:101053. doi: 10.1016/j.blre.2023.101053. Epub 2023 Feb 3.
Matched unrelated donor transplants-State of the art in the 21st century.
Altaf SY, Apperley JF, Olavarria E.
Semin Hematol. 2016 Oct;53(4):221-229. doi: 10.1053/j.seminhematol.2016.07.002. Epub 2016 Jul 25.
Haploidentical Versus Matched Unrelated Donor Transplants Using Post-Transplantation Cyclophosphamide for Lymphomas.
Mussetti A, Kanate AS, Wang T, He M, Hamadani M, Finel H Sr, Boumendil A Sr, Glass B, Castagna L, Dominietto A, McGuirk J, Blaise D, Gülbas Z, Diez-Martin J, Marsh SGE, Paczesny S, Gadalla SM, Dreger P, Zhang MJ, Spellman SR, Lee SJ, Bolon YT, Sureda A.
Transplant Cell Ther. 2023 Mar;29(3):184.e1-184.e9. doi: 10.1016/j.jtct.2022.11.028. Epub 2022 Dec 25.
Donor selection in allogeneic stem cell transplantation.
Barriga F, Lima ACM.
Curr Opin Hematol. 2024 Nov 1;31(6):261-269. doi: 10.1097/MOH.0000000000000831. Epub 2024 Jul 15.
Matched Unrelated Donor Hematopoietic Cell Transplantation: Increased Usage and Improvements in Clinical Outcomes in Canada.
Seftel MD, Musto G, Allan D, Bucher O, Hay K, Pasic I, Truong T, Paulson K.
Curr Oncol. 2024 Dec 27;32(1):10. doi: 10.3390/curroncol32010010.
Outcomes with HLA-matched unrelated donor versus haploidentical hematopoietic cell transplantation.
Mushtaq MU, Shahzad M, Amin MK, Lutfi F, DeJarnette S, Al-Ramahi JS, Li K, Ahmed N, Bansal R, Abdelhakim H, Shune L, Abdallah AO, Abhyankar SH, McGuirk JP, Singh AK.
Leuk Lymphoma. 2024 Apr;65(4):493-502. doi: 10.1080/10428194.2023.2300708. Epub 2024 Jan 2.
A clinician's guide to HLA matching in allogeneic hematopoietic stem cell transplant.
Mangum DS, Caywood E.
Hum Immunol. 2022 Oct;83(10):687-694. doi: 10.1016/j.humimm.2022.03.002. Epub 2022 Mar 25.
The use of haploidentical stem cell transplant as an alternative donor source in patients with decreased access to matched unrelated donors.
Graham C, Litzow M.
Hematology. 2024 Dec;29(1):2338300. doi: 10.1080/16078454.2024.2338300. Epub 2024 May 16.
Matched and mismatched unrelated donor transplantation: is the outcome the same as for matched sibling donor transplantation?
Bacigalupo A.
Hematology Am Soc Hematol Educ Program. 2012;2012:223-9. doi: 10.1182/asheducation-2012.1.223.
